PT100724A - Processo de determinacao da quantidade de grupos tiol ligados em proteinas e conjunto para a deteccao de estados isquemicos - Google Patents

Processo de determinacao da quantidade de grupos tiol ligados em proteinas e conjunto para a deteccao de estados isquemicos

Info

Publication number
PT100724A
PT100724A PT100724A PT10072492A PT100724A PT 100724 A PT100724 A PT 100724A PT 100724 A PT100724 A PT 100724A PT 10072492 A PT10072492 A PT 10072492A PT 100724 A PT100724 A PT 100724A
Authority
PT
Portugal
Prior art keywords
proteins
determination
detection
ischemic states
groups connected
Prior art date
Application number
PT100724A
Other languages
English (en)
Other versions
PT100724B (pt
Inventor
David Bar-Or
Clive Solomons
Original Assignee
Diagnostic Markers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Markers Inc filed Critical Diagnostic Markers Inc
Publication of PT100724A publication Critical patent/PT100724A/pt
Publication of PT100724B publication Critical patent/PT100724B/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/903—Diazo reactions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/904—Oxidation - reduction indicators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
PT100724A 1991-07-26 1992-07-24 Processo de determinacao da quantidade de grupos tiol ligados em proteinas e conjunto para a deteccao de estados isquemicos PT100724B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/736,583 US5227307A (en) 1991-07-26 1991-07-26 Test for the rapid evaluation of ischemic state

Publications (2)

Publication Number Publication Date
PT100724A true PT100724A (pt) 1993-09-30
PT100724B PT100724B (pt) 1999-07-30

Family

ID=24960447

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100724A PT100724B (pt) 1991-07-26 1992-07-24 Processo de determinacao da quantidade de grupos tiol ligados em proteinas e conjunto para a deteccao de estados isquemicos

Country Status (15)

Country Link
US (2) US5227307A (pt)
EP (2) EP1411356B1 (pt)
JP (1) JP3194952B2 (pt)
KR (1) KR100239947B1 (pt)
AT (2) ATE290688T1 (pt)
AU (2) AU2318792A (pt)
BR (1) BR9206312A (pt)
CA (2) CA2520598A1 (pt)
DE (2) DE69233487T2 (pt)
DK (1) DK0596925T3 (pt)
ES (1) ES2239753T3 (pt)
IE (2) IE922421A1 (pt)
NO (1) NO313900B1 (pt)
PT (1) PT100724B (pt)
WO (1) WO1993003346A1 (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733524A (en) * 1984-03-19 1998-03-31 The Picower Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5217594A (en) * 1992-01-15 1993-06-08 Enzyme Technology Research Group, Inc. Convenient determination of trace lead in whole blood and other fluids
US5281700A (en) * 1992-08-11 1994-01-25 The Regents Of The University Of California Method of recovering endothelial membrane from tissue and applications thereof
NZ294919A (en) * 1994-10-27 1998-08-26 Oxigene Inc Method for testing immune competency of individual; determining total plasma/serum thiols for individual from blood sample
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
WO2000020840A1 (en) * 1998-10-02 2000-04-13 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US6461875B1 (en) * 1998-10-02 2002-10-08 Ischemia Technologies, Inc. Test for rapid evaluation of ischemic states and kit
US7070937B1 (en) * 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7449338B2 (en) * 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
JP2002526764A (ja) * 1998-10-02 2002-08-20 イスケミア・テクノロジーズ・インコーポレーテッド 虚血状態の迅速鑑定のための検査およびキット
US20030215952A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US6492179B1 (en) * 1998-10-02 2002-12-10 Ischemia Techologies, Inc. Test for rapid evaluation of ischemic states and kit
US6475743B1 (en) * 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
AU2002305731A1 (en) * 2001-05-30 2002-12-09 Ischemia Technology, Inc. Method and system for optically performing an assay to determine a medical condition
US7262017B2 (en) 2001-09-14 2007-08-28 Torrey Pines Institute For Molecular Studies Diagnostic markers for ischemia
CA2468236A1 (en) * 2001-11-26 2003-06-05 Ischemia Technologies, Inc. Electrochemical detection of ischemia
EP2386863A1 (en) * 2002-10-09 2011-11-16 DMI Biosciences, Inc. Diagnosis and monitoring of multiple organ failure
US6884218B2 (en) * 2002-12-09 2005-04-26 Charles W. Olson Three dimensional vector cardiograph and method for detecting and monitoring ischemic events
AU2002359693A1 (en) * 2002-12-13 2004-07-09 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
EP1479779A1 (en) * 2003-05-19 2004-11-24 Eppendorf Array Technologies SA Biological signature of manufactured products
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
EP2821793B1 (en) * 2004-03-22 2017-04-19 FFA Sciences, LLP Development and use of fluorescent probes of unbound analytes
EP1856645A4 (en) * 2005-01-21 2009-12-30 Ischemia Tech Inc TARGETS FOR THE DETECTION OF ISCHEMIA
US20060199280A1 (en) * 2005-03-03 2006-09-07 David Bar-Or Quantification of proteins
US20060257938A1 (en) * 2005-05-10 2006-11-16 Kleinfeld Alan M Method of screening for drugs that block ligand binding to a lipid binding protein
WO2008060841A2 (en) 2006-10-27 2008-05-22 Ffa Sciences, Llc Use of probes for unbound metabolites
EP1975613B1 (en) * 2007-03-29 2012-07-18 L'Oréal Kits and methods for evaluating hair damage
US8709709B2 (en) 2007-05-18 2014-04-29 Luoxis Diagnostics, Inc. Measurement and uses of oxidative status
CA2684144C (en) * 2007-05-18 2018-03-27 Institute For Molecular Medicine, Inc. Measurement and uses of oxidative status
JP5172467B2 (ja) * 2008-05-22 2013-03-27 日本電信電話株式会社 血液中成分の定量分光分析法
ES2658709T3 (es) 2011-02-28 2018-03-12 Aytu Bioscience, Inc. Aparato para medir el potencial oxidación-reducción
CN102323255B (zh) * 2011-05-30 2013-08-14 吉权 一种缺血修饰白蛋白测定显色剂及其制备方法
KR101187648B1 (ko) 2011-08-18 2012-10-09 한국원자력연구원 티올기 검출을 위한 바이오 센서 및 이의 제조방법
EP2839273A4 (en) 2012-04-19 2016-02-10 Aytu Bioscience Inc MULTILAYER GEL
CA2847665A1 (en) 2012-10-23 2014-04-23 Raphael Bar-Or Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
WO2016025430A1 (en) 2014-08-11 2016-02-18 The Board Of Trustees Of The University Of Illinois Epidermal photonic systems and methods
JP6744019B2 (ja) 2014-08-11 2020-08-19 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ 生物流体の表皮特性評価のためのデバイス及び関連する方法
CN106999060A (zh) 2014-08-11 2017-08-01 伊利诺伊大学评议会 用于分析温度特性和热传送特性的表皮器件
EP3223747B1 (en) 2014-11-25 2020-09-02 Aytu BioScience, Inc. Determination of fertility potential from the oxidation-reduction potential of a biological sample
WO2017116358A1 (en) 2015-12-28 2017-07-06 Oran Ismail Method and apparatus for determination of fatty acid markers using electrical impedance measurement
WO2019238554A1 (en) 2018-06-11 2019-12-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting the risk of having lower-extremity artery disease in patients suffering from type 2 diabetes
CN109557322A (zh) * 2018-12-13 2019-04-02 蓝怡科技集团股份有限公司 一种缺血修饰白蛋白校准品及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795221A (fr) * 1972-02-12 1973-08-09 Merck Patent Gmbh Procede et reactif rapide en vue de deceler des stupefiants
US4434234A (en) * 1981-04-02 1984-02-28 The Upjohn Company Method and kit for silver staining substances supported in matrix
US4379848A (en) * 1981-09-28 1983-04-12 Eastman Kodak Company Method of analyzing an aqueous liquid for hexacyanoferrates
US4468466A (en) * 1982-02-16 1984-08-28 The United States Of America As Represented By The Department Of Health And Human Services Silver stains for protein in gels--a modified procedure
US4492753A (en) * 1982-10-06 1985-01-08 Immudx, Inc. Method and means for assessment and prediction of risk of subsequent ischemic cardiac events
US4486282A (en) * 1983-02-22 1984-12-04 University Patents, Inc. Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis
US4713327A (en) * 1985-05-01 1987-12-15 Eastman Kodak Company Determination of total creatine kinase or an isoenzyme with a multilayer analytical element
JPH0625762B2 (ja) * 1985-06-13 1994-04-06 ヤマサ醤油株式会社 ミオシン軽鎖の測定法
AU7397487A (en) * 1986-03-25 1987-10-20 Mclas Technologies, Inc. Microchemiluminescent assay for detection and quantification of oxidative injury to cells
US4786605A (en) * 1987-06-22 1988-11-22 Eastman Kodak Company Analytical method and element for protein assay

Also Published As

Publication number Publication date
BR9206312A (pt) 1995-04-11
IE922421A1 (en) 1993-01-27
AU1000697A (en) 1997-03-20
WO1993003346A1 (en) 1993-02-18
KR100239947B1 (en) 2000-01-15
US5227307A (en) 1993-07-13
EP0596925B1 (en) 2005-03-09
US5290519A (en) 1994-03-01
JP3194952B2 (ja) 2001-08-06
DE69233487D1 (de) 2005-04-14
ES2239753T3 (es) 2005-10-01
EP0596925A1 (en) 1994-05-18
AU2318792A (en) 1993-03-02
IE20050515A1 (en) 2005-09-21
DK0596925T3 (da) 2005-05-23
EP1411356A2 (en) 2004-04-21
ATE290688T1 (de) 2005-03-15
AU705300B2 (en) 1999-05-20
DE69233757D1 (de) 2009-04-16
NO940256D0 (pt) 1994-01-25
EP1411356A3 (en) 2004-05-12
CA2520598A1 (en) 1993-02-18
PT100724B (pt) 1999-07-30
NO940256L (no) 1994-01-25
NO313900B1 (no) 2002-12-16
EP1411356B1 (en) 2009-03-04
CA2113266A1 (en) 1993-02-18
DE69233487T2 (de) 2006-01-19
CA2113266C (en) 2006-01-10
EP0596925A4 (en) 1996-02-14
JPH06509645A (ja) 1994-10-27
ATE424559T1 (de) 2009-03-15

Similar Documents

Publication Publication Date Title
PT100724A (pt) Processo de determinacao da quantidade de grupos tiol ligados em proteinas e conjunto para a deteccao de estados isquemicos
TW326074B (en) Methods, kits and diagnostic systems for performing an affinity assay
DE69429770D1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
EP0335244A3 (en) Solid-phase analytical device and method for using same
BR9406944A (pt) Processos para a determinaçao imunológica para determinar de niveis de fibrinogênio no plasma IN VITRO,para a detecçao IN VITRO de polimeros de fibrina solúveis e polimeros de fibrina nao reticuladossoluveis em uma amostra de mamifero,e,em uma amostra de mamifero daquelas especies que formam um complexo com o anticorpo MH1 ,e kit para determinacaoda quantidade de polimeros de fibrina
ES524101A0 (es) Un metodo inmunocromatografico para determinar la presencia de un determinado componente analizable en una muestra que contiene dicho componente.
ATE515693T1 (de) Nachweis einer zielsubstanz in einer probe
ES2054617T3 (es) Nuevo metodo para la deteccion y/o determinacion cuantitativa de agentes ligantes especificos y sus correspondientes sustancias ligables.
ATE461450T1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
ES2118062T3 (es) Composiciones reactivas, metodos y reactivos para la valoracion cuantitativa de magnesio o de calcio y magnesio.
DE69223510D1 (de) Verfahren und reagenzien zur ausführung von ioneneinfang-digoxin-assays
DK0696642T3 (da) Fremgangsmåde til påvisning af forstyrrelser i protein C/protein S-systemet
ATE333091T1 (de) Verfahren zur messung von blutersatzstoffen
DE69226526D1 (de) Reagenzien und verfahren zur ausführung eines zweistufigen ioneneinfang-assay
SE9502024D0 (sv) Pathogen assay method
DE69529691D1 (de) Differenziertes timingsverfahren zum nachweiss multiple analyte in eine testprobe
DE60028190D1 (de) Verfahren zur quantifizierung von cholesterin
DE60121547D1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
KR910001378A (ko) HIV p24 정량 패널

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930507

FG3A Patent granted, date of granting

Effective date: 19990414

PC3A Transfer or assignment

Free format text: 20000207 ISCHEMIA TECHNOLOGIES, INC. US

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20091014